A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
Clinical trial NCT07596849 · RECRUITING
Trial details
- NCT number
- NCT07596849
- Sponsor
- argenx
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-10
- Primary completion
- 2028-06-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.